A phase I study of accelerated high dose epirubicin (HDE) and cisplatin with G-CSF support in patients with advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Smit, EF [1 ]
Postmus, PE [1 ]
机构：
[1] Vrije Univ Amsterdam, Acad Hosp, Dept Pulm Dis, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP143
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [41] Gemcitabine combined with cisplatin in non-small cell lung cancer (NSCLC): A phase I/II study
    Steward, WP
    Dunlop, DJ
    Cameron, C
    Talbot, DC
    Kleisbauer, JL
    Thomas, P
    Guerin, JC
    Perol, M
    Sanson, C
    Dabouis, G
    Lacroix, H
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1081 - 1081
  • [42] Phase I study of azacitidine and cisplatin in patients with advanced head and neck or non-small cell lung cancer
    Liao, Yu-Min
    Mirshahidi, Hamid
    Zhang, Kangling
    Mirshahidi, Saied
    Williamson, Stephen
    Hsueh, Chung-Tsen
    CANCER RESEARCH, 2012, 72
  • [43] Phase I study of amrubicin and cisplatin in previously untreated patients with advanced non-small-cell lung cancer
    Yoshimura, N.
    Kudoh, S.
    Kimura, T.
    Mitsuoka, S.
    Yana, T.
    Hirata, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer
    Gatzemeier, U
    von Pawel, J
    Gottfried, M
    ten Velde, GPM
    Mattson, K
    DeMarinis, F
    Harper, P
    Salvati, F
    Robinet, G
    Lucenti, A
    Bogaerts, J
    Gallant, G
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) : 3390 - 3399
  • [45] A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer
    Hotta, K
    Sekine, I
    Tamura, T
    Sawada, M
    Watanabe, H
    Kusaba, H
    Akiyama, Y
    Inoue, A
    Shimoyama, T
    Nokihara, H
    Ueda, Y
    Yamamoto, N
    Kunitoh, H
    Ohe, Y
    Kodama, T
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (12) : 596 - 600
  • [46] PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN AND ETOPOSIDE IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    SMIT, EF
    PIERS, DA
    POSTMUS, PE
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (12) : 1965 - 1967
  • [47] Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer
    Makatsoris, Thomas
    Papakostas, Pavlos
    Kalofonos, Haralahos P.
    Xanthakis, Loannis
    Tsavdaridis, Dimitrios
    Aravantinos, Gerasimos
    Gogas, Helen
    Klouvas, George
    Kosmidis, Paris
    Pectasides, Dimitrios
    Fountzilas, George
    MEDICAL ONCOLOGY, 2007, 24 (03) : 301 - 307
  • [48] A phase I study of irinotecan and infusional cisplatin for advanced non-small-cell lung cancer
    K. Mori
    Tsukasa Ohnishi
    Kohki Yokoyama
    Keigo Tominaga
    Cancer Chemotherapy and Pharmacology, 1997, 39 : 327 - 332
  • [49] A phase I study of weekly docetaxel and cisplatin in advanced non-small cell lung cancer
    Sato, K
    Tsuchiya, S
    Minato, K
    Takei, Y
    Watanabe, S
    Saitoh, R
    Mori, M
    LUNG CANCER, 2001, 33 (01) : 69 - 73
  • [50] A phase I study of irinotecan and infusional cisplatin for advanced non-small-cell lung cancer
    Mori, K
    Ohnishi, T
    Yokoyama, K
    Tominaga, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 39 (04) : 327 - 332
12345